CTR1 Silencing Inhibits Angiogenesis by Limiting Copper Entry into Endothelial Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Narayanan, Gomathy ^a,b   Bharathidevi, S R ^a   Vuyyuru, Harish ^a   Muthuvel, Bharathselvi ^a,b   Konerirajapuram Natrajan, Sulochana ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COPPER; COPPER TRANSPORTER 1; MESSENGER RNA; PENICILLAMINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CATION TRANSPORT PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COPPER; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883652029     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071982     Document Type: Article

References (42)

1. Folkman J, (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409-416.
2. van Hinsbergh VW, Koolwijk P, (2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78: 203-212.
3. Papetti M, Herman IM, (2002) Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-970.
4. Carmeliet P, (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
5. Riely GJ, Miller VA, (2007) Vascular endothelial growth factor trap in non small cell lung cancer. Clin Cancer Res 13: s4623-4627.
6. Elice F, Rodeghiero F, (2012) Side effects of anti-angiogenic drugs. Thromb Res 129 Suppl 1: S50-53.
7. Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, et al. (2012) Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst 104: 93-113.
8. El Filali M, Ly LV, Luyten GP, Versluis M, Grossniklaus HE, et al. (2012) Bevacizumab and intraocular tumors: an intriguing paradox. Mol Vis 18: 2454-2467.
9. Lowndes SA, Harris AL, (2005) The role of copper in tumour angiogenesis. J Mammary Gland Biol Neoplasia 10: 299-310.
10. Harris ED, (2004) A requirement for copper in angiogenesis. Nutr Rev 62: 60-64.
11. Bertinato J, Cheung L, Hoque R, Plouffe LJ, (2010) Ctr1 transports silver into mammalian cells. J Trace Elem Med Biol 24: 178-184.
12. Hu GF, (1998) Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 69: 326-335.
13. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, et al. (2002) Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 282: H1821-1827.
14. Feng W, Ye F, Xue W, Zhou Z, Kang YJ, (2009) Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol 75: 174-182.
15. Jiang Y, Reynolds C, Xiao C, Feng W, Zhou Z, et al. (2007) Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 204: 657-666.
16. McAuslan BR, Gole GA, (1980) Cellular and molecular mechanisms in angiogenesis. Trans Ophthalmol Soc U K 100: 354-358.
17. Juarez JC, Betancourt O Jr, Pirie-Shepherd SR, Guan X, Price ML, et al. (2006) Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res 12: 4974-4982.
18. Boal AK, Rosenzweig AC, (2009) Structural biology of copper trafficking. Chem Rev 109: 4760-4779.
19. Schushan M, Barkan Y, Haliloglu T, Ben-Tal N, (2010) C(alpha)-trace model of the transmembrane domain of human copper transporter 1, motion and functional implications. Proc Natl Acad Sci U S A 107: 10908-10913.
20. Banci L, Bertini I, Cantini F, Ciofi-Baffoni S, (2010) Cellular copper distribution: a mechanistic systems biology approach. Cell Mol Life Sci 67: 2563-2589.
21. Sharp PA, (2003) Ctr1 and its role in body copper homeostasis. Int J Biochem Cell Biol 35: 288-291.
22. Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, et al. (2007) BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 17: 316-322.
23. Ryther RC, Flynt AS, Phillips JA 3rd, Patton JG, (2005) siRNA therapeutics: big potential from small RNAs. Gene Ther 12: 5-11.
24. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M, (2007) A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2: 481-485.
25. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, et al. (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22: 326-330.
26. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
27. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
28. Lou JR, Zhang XX, Zheng J, Ding WQ, (2010) Transient metals enhance cytotoxicity of curcumin: potential involvement of the NF-kappaB and mTOR signaling pathways. Anticancer Res 30: 3249-3255.
29. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333.
30. Zarrabi K, Dufour A, Li J, Kuscu C, Pulkoski-Gross A, et al. (2011) Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. J Biol Chem 286: 33167-33177.
31. Lee J, Petris MJ, Thiele DJ, (2002) Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. J Biol Chem 277: 40253-40259.
32. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY, (2007) Function and regulation of human copper-transporting ATPases. Physiol Rev 87: 1011-1046.
33. Barry AN, Shinde U, Lutsenko S, (2010) Structural organization of human Cu-transporting ATPases: learning from building blocks. J Biol Inorg Chem 15: 47-59.
34. Tumer Z, Moller LB, (2010) Menkes disease. Eur J Hum Genet 18: 511-518.
35. Ashino T, Sudhahar V, Urao N, Oshikawa J, Chen GF, et al. (2010) Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration. Circ Res 107: 787-799.
36. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, et al. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464: 1067-1070.
37. Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, et al. (2010) RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol 150: 33-39 e32.
38. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T, (2002) Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110: 563-574.
39. Holen T, Amarzguioui M, Babaie E, Prydz H, (2003) Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res 31: 2401-2407.
40. Qiu L, Ding X, Zhang Z, Kang YJ, (2012) Copper is required for cobalt-induced transcriptional activity of hypoxia-inducible factor-1. J Pharmacol Exp Ther 342: 561-567.
41. Krupanidhi S, Sreekumar A, Sanjeevi CB, (2008) Copper & biological health. Indian J Med Res 128: 448-461.
42. Brem S, Grossman SA, Carson KA, New P, Phuphanich S, et al. (2005) Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol 7: 246-253.